Nektar Therapeutics to report Q2 results after U.S. market close, hosts conference call

• Nektar Therapeutics schedules Q2 2026 results for Aug. 13, 2026, released post-close.
• Results conference call set for Aug. 13, 2026 at 5 p.m. ET; webcast via https://ir.nektar.com/.
• Webcast replay available through Sept. 13, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nektar Therapeutics published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607281800PR_NEWS_USPR_____SF14170) on July 28, 2026, and is solely responsible for the information contained therein.